Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Tubulis GmbH
Eli Lilly and Company
Merus B.V.
Betta Pharmaceuticals Co., Ltd.
Theravectys S.A.
Perspective Therapeutics
Second Life Therapeutics
Onchilles Pharma Inc
Eli Lilly and Company
Kura Oncology, Inc.
VM Oncology, LLC
Takeda
BicycleTx Limited
Eli Lilly and Company
ITM Oncologics GmbH
LigaChem Biosciences, Inc.
Coordination Pharmaceuticals, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Hoffmann-La Roche
Rapa Therapeutics LLC
Alume Biosciences, Inc.
GeoVax, Inc.
Intensity Therapeutics, Inc.
Alentis Therapeutics AG
PureTech
Psivac Ltd
BioAtla, Inc.
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
Atara Biotherapeutics
Jacobio Pharmaceuticals Co., Ltd.
Purple Biotech Ltd.
Compugen Ltd
SCG Cell Therapy Pte. Ltd.
iTeos Therapeutics
Innolake Biopharm
GeneMedicine Co., Ltd.
SQZ Biotechnologies
CytomX Therapeutics
CytomX Therapeutics
SecuraBio
Genmab